bioAffinity Technologies Files Presentation for H.C. Wainwright Conference

What Happened
bioAffinity Technologies, Inc. filed a Form 8-K on September 11, 2026 (Item 7.01) disclosing that it prepared presentation materials management will use in presentations, including at the H.C. Wainwright 28th Annual Global Investment Conference scheduled for September 14–16, 2026. The Presentation Materials are furnished as Exhibit 99.1 to the 8-K.

Key Details

• 8-K filed September 11, 2026 under Item 7.01 (Regulation FD Disclosure).
• Presentation to be used at H.C. Wainwright conference, Sept 14–16, 2026.
• Presentation Materials are attached as Exhibit 99.1 to the filing; the filing also includes the interactive cover page XBRL file (Exhibit 104).
• The filing does not report earnings, financial results, or management changes.

Why It Matters
This 8-K signals that bioAffinity will present updated information to investors at a major broker-hosted conference. Investors who follow the company should review the furnished presentation (Exhibit 99.1 on the SEC EDGAR filing) for any operational or strategic updates that could affect sentiment or trading. The 8-K itself does not contain financial statements or executive changes.